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The Politics of Institutionalizing Preventative Health 
 
Abstract 
Prevention is an attractive idea to policymakers in theory, particularly in health where the 
burden of spending and care is increasingly taken up by complex and chronic conditions 
associated with lifestyle choices. However, prevention in general, and preventative health in 
particular, has proven hard to implement in practice. In this paper, we look to one tangible 
legacy of the recent rise of the prevention agenda: agencies with responsibility for 
preventative health policy. We ask how this form of institutionalizing preventative health 
happens in practice, and what consequences it has for the advancement of the prevention 
agenda.  We draw on qualitative data to compare the trajectories of newly formed agencies in 
Australia, New Zealand and England. We find that building and maintaining legitimacy for 
such agencies may come at the expense of quick progress or radical action in service of the 
prevention agenda. 
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Introduction 
Advocates of preventative health are fond of using the metaphor of the ambulance at the 
bottom of the cliff to describe the overwhelming political attention and government funding 
devoted to acute health services. They argue that short-term political priorities and ‘siloed’ 
governance structures perpetuate the dominant vision of healthcare as providing a ‘sickness 
service’ rather than a ‘wellness service’. They point instead to the rising burden of non-
communicable diseases (NCDs) on healthcare systems, and call for greater attention towards 
a range of measures to rope off the top of the cliff before the problem arises rather than 
parking an ambulance at the bottom when it is all but too late. 
But institutionalizing prevention, by turning this persuasive logic into policymaking rules and 
action, has proven very difficult in practice. From calls for fundamental reform to include 
‘health-in-all policies’ through to more modest proposals for targeted action on issues like 
product reformulation, ‘sin’ taxes, or regulation of advertising and marketing, change has 
been slow, limited, piecemeal, and more often thwarted altogether. Cross-national studies of 
progress on this agenda suggest that such efforts continue to be hampered by a lack of clarity, 
funding, leadership and/or ‘ownership’ and accountability (Guglielmin et al, 2018).  
To address this shortfall, there have been growing calls to embed prevention within the 
institutional architecture of government itself. In practice, advocacy has coalesced especially 
around the idea of establishing executive agencies - bodies with operational autonomy from 
government departments and direct access to the executive - with responsibility for 
preventative health. The hope is that these agencies can act as vehicles to coordinate 
resources, provide leadership and momentum, and influence decision-makers from inside 
government, lifting the cause of preventative health above politics-as-usual and enabling 
meaningful policy change in the long term (Moody et al. 2008; WHO 2014).  
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In recent times, this approach to institutionalizing preventative health has been relatively 
successful. But is the proliferation of agencies really such a boon for the prevention agenda in 
health? Are agencies the effective vehicles for driving significant, long-term policy change 
that their advocates hope for? Some thoughtful research in public health begins to unpack 
some of the trade-offs and challenges these agencies face in practice (Schang et al. 2011). 
Delving deeper into the policy and administration literature reveals that agencies in general 
are typically fragile (James et al. 2015; Boin et al. 2010). Most fail in the short to medium-
term, and even those which succeed in the long-term can be subject to swingeing cuts 
(Dommett and Skelcher 2014; O’Leary 2015). Agencies should not be treated as a simple fix.  
We investigate recent efforts to institutionalize preventative health via dedicated agencies. 
We ask how this form of institutionalization happens in practice, and what consequences it 
has for the advancement of the prevention agenda. We conduct a comparative case analysis 
that tracks the birth, life and (in one case) death of new agencies with responsibility for 
preventative health in Australia, New Zealand and England. Drawing on policy documents 
and semi-structured interviews with 25 officials and stakeholders, we explain the different 
failings of the Australian National Preventive Health Agency (ANPHA) and New Zealand’s 
Health Promotion Association (HPA), and the relative success of Public Health England 
(PHE). We show that an agency is far from a silver bullet for the prevention cause. Instead, 
we identify the key dilemmas that the advocates and architects of these new bodies face: 
whether to court or avoid conflict with key stakeholders, how to shape the remit of agency 
activities and responsibilities in contested policy terrain, and how to establish long-term 
credibility. Our account of the distinct trajectories of these three agencies highlights key 
lessons for the public health community:  
a) creating agencies cannot solve the prevention problem, as the viability of agencies 
depends on a complex configuration of factors which shift over time;  
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b) such agencies may actually serve this agenda better by emphasising technical 
public health programmes and sneaking prevention in the back door rather than by 
offering the bold advocacy many envisage; and  
c) building and maintaining widespread legitimacy for such agencies, and their work, 
may come at the expense of quick progress or radical action. 
The paper proceeds in five sections. The first provides a critical review of the prevention 
agenda, focused on the institutionalisation of preventative health through dedicated agencies. 
The second synthesises the policy and administration scholarship on the challenges and 
successes of agencies to develop an analytical framework for the case studies. The third 
explains the case selection and data collection. The fourth presents the three cases, and 
clarifies the affinities and discrepancies across them. The fifth draws together these findings 
to identify the key implications for the prevention agenda in health. 
 
Institutionalising prevention: The long and difficult journey from ideas to action 
Prevention is part of an intuitively appealing slogan: intervening early to stop bad outcomes 
from arising is better than fixing them when they have emerged, particularly if it saves lives 
and money.  However, ‘prevention is better than cure’ remains an idiom and vague ambition 
until policymakers cooperate to turn it into specific policies and policymaking practices. To 
do so, they must make choices regarding: how to define the problem (such as in relation to 
costs or inequalities); which interventions to support (such as by redistributing income, 
encouraging behavioural change, or regulating individual behaviour); when to intervene in 
people’s lives (focusing on the whole population, high risk, or already affected groups); and, 
how to connect prevention to complementary aims such as ‘evidence based policymaking’, 
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‘joined up government’ and local or service-user driven services (Cairney and St Denny, 
2019). During this process, contentious choice undermines superficial consensus (Billis, 1981: 
367). Although prevention advocates may see prevention ‘ecologically’, as a large collection 
of actions that interact to become greater than the sum of their parts (McLeroy et al. 1988; 
Stokols 1996), policymakers are under pressure to make and defend specific choices.  
In that context, Cairney and St Denny (2019) identify commonly described obstacles to 
prevention, which can be summed up in the following narrative. Policymakers do not realise 
the scale of their task until they start to define prevention in practice, to produce strategies 
and detailed objectives. In doing so, they encounter major trade-offs between long-term 
preventive aims and their short-term objectives, such as to remain popular by demonstrating 
their competence to govern reactive public services. They devote most resources, such as 
attention, staffing, spending, and performance management to reactive services. Even when 
opportunity to devote limited resources to prevention presents itself, it is seldom clear what 
policy options they ought to prioritise or support. They find the evidence base to be limited 
and no substitute for political choice. They engage with a range of public health experts, 
some of whom advocate vociferously for policy change and others who do not want to get 
ahead of the evidence.  By making choices, they signal their intention to regulate individual, 
family, and social life and portray many people and their ‘lifestyle choices’ negatively. These 
choices are divisive, generating mixed public support and some dissent among the 
organisations and professionals responsible for delivery. Many policymakers begin to think 
of problems as too ‘wicked’ to solve meaningfully with the resources at their disposal (Rittell 
and Webber, 1973; McConnell, 2017).  
This narrative highlights the historical difficulties in moving prevention from abstract ideal to 
concrete institutionalisation: the processes by which policy-related rules, ideas, procedures, 
and goals take on “a rulelike status in social thought and action” (Meyer and Rowan, 1991: 
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42). There are many different forms of institutionalisation, from rules that are fundamental, 
permanent and wide-ranging to exhortations that are more symbolic, fleeting or narrowly 
limited.  
At the ambitious end of the scale, the ultimate aim of the prevention agenda may be 
mainstreaming: the “(re)organisation, improvement, development and evaluation of policy 
processes so that a [certain policy perspective] is incorporated in all policies at all levels and 
at all stages, by actors normally involved in policymaking” (Council of Europe, 1998: 15). 
The goal is to counter the impact of entrenched biases on the (re)production of inequalities 
and suboptimal outcomes (Donaghy, 2004). Mainstreaming prevention in health is an idea 
that finds common expression in ‘healthy public policy’ or the notion of ‘health-in-all-
policies’, whereby all government policies and programmes are evaluated on the basis of 
their impact on population health and health equity (The Helsinki Statement on Health in All 
Policies, 2014). 
However, the obstacles to encoding regulations and practices associated with mainstreaming 
prevention go far beyond a vague notion of low ‘political will’ to include low clarity about 
what prevention means – and should mean - in practice. Most public health advocates are 
pragmatic enough to see mainstreaming as a long term ambition. In the meantime, they focus 
on a joining up more moderate and specific policy proposals; the ‘low-hanging fruit’ of 
feasible and attractive solutions for policymakers which can, when applied together in a 
synergistic manner, have a positive impact on prevention (Boswell 2016, Ch 2). Measures in 
this ‘ecology’ of intervention include: product reformulation; restrictions on marketing of 
unhealthy products; and taxes on alcohol, tobacco and unhealthy foods. Yet, progress even on 
this more modest agenda has been slow and frustrating.  
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Ultimately, where public health advocates have been able to achieve a greater measure of 
success in the last two decades is in an alternative approach known more broadly as 
substantive institutionalisation (Corcoran 2011). It refers to the creation of positions or 
functions in government dedicated to promoting and developing a particular service, policy 
goal or agenda. Though substantive institutionalisation can take a variety of forms (Hogwood 
et al, 2001), in this sector it is associated especially with the establishment of departmental 
executive agencies. Agencies are dedicated bodies with operational autonomy from line 
departments and (usually) direct access to the executive. They are integrated within 
government (to help coordinate policymaking functions) but operate sufficiently 
autonomously to ensure that their implementation objectives are not necessarily affected by 
changing political context and elected policymakers’ fluctuating attention (Verhoest, 2013: 
52).   
Due partly to celebrated ‘success stories’ like VicHealth (in the Australian state of Victoria) 
and the Thai Health Promotion Foundation (McQueen 2016), preventative health advocates 
see executive agencies as useful vehicles for driving policy change (for examples in public 
health scholarship, see Harris and Mortimer 2009; Catford 2009; Perez 2013; Friel 2013; 
McQueen 2016; for examples in public health advocacy, see Watt 2005; Moodie et al. 2008; 
WHO 2014; Sopitarcharsak et al. 2015). Across many jurisdictions, advocates have fought 
for the establishment of agencies which can concentrate resources, ensure access to key 
decision-makers, and boost the leadership required to challenge the dominant healthcare 
paradigm and lift prevention policies beyond the realm of politics-as-usual.  
But the story does not end there. The generalist public administration and public policy 
literatures tell us that agencies are no simple fix. They remain vulnerable to damaging or fatal 
public contestation and political interference.  There is a need to interrogate whether agencies 
with responsibility for preventative health are durable solutions that can live up to the hopes 
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advocates have invested in them. We ask: how has this form of institutionalizing preventative 
health happened in practice, and what consequences has it had for the advancement of the 
prevention agenda? The following section sets out a framework for answering these questions. 
 
Understanding the vicissitudes of agencies: A framework for interpretation 
The literature on agencies in public administration has ballooned in response to their 
widespread proliferation in the last two or three decades. Tremendous empirical focus has 
gone into explaining the variation in their ‘success’, understood usually in terms of their 
longevity and perceived legitimacy. But attempts to map success on these grounds have failed 
to reveal clear patterns. Indeed, an authoritative meta-analysis writes off their fate as ‘random’ 
(Verhoest 2012). 
However, recent scholarship emphasises the importance of an interpretive orientation to 
understanding patterns of organisational birth and death based on in-depth qualitative 
research (Elston 2014; 2017). Interpretivists see organisations not as fixed structures that 
determine political and policy outcomes, but as contingent and fluid configurations that 
reflect and reinforce prevailing political dynamics (Bevir and Rhodes 2003). Simply-
expressed ‘variables’ cannot explain organisations’ fate across time and space. They are 
liable to change over time and to have different meanings and implications in different 
contexts.  As such,  turning to insights from qualitative, interpretive forms of research can 
help us gain deeper insight into the configuration of factors that influence the success or 
failure of agencies (Flinders and Skelcher 2012; Flinders et al. 2014). A critical review of this 
literature suggests that issues of salience, scope and standing are particularly crucial to 
explain their success.  
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Salience: The extent to which the substantive area in which an agency works is politicised by 
controversial media coverage or association with partisan alignment.  
Governments appear less likely to surrender control to an agency in the context of a 
politically salient issue. Further, actors within and outside government are more likely to 
impugn the legitimacy of existing agencies that intersect with salient political issues, 
particularly if their genesis is associated with a rival party (Koop 2011; Park 2013; Bertelli et 
al. 2015; James et al. 2016). Yet, agencies are also ‘useful’ when they help depoliticise 
contentious issues; governments portray the issue as above party politics and ‘kick it to the 
long grass’ to insulate themselves from blame (Hood 2002; Flinders 2008; Lavertu 
2015).  Recent case research shows how these dynamics intersect in messy ways. Wood’s 
(forthcoming) comparative analysis of agencies - devoted to environmental protection, health 
prioritisation and water governance - reveals that increasing salience does not determine the 
fate of an agency either way. Rather, it presents actors with new challenges and opportunities. 
Their response to different dynamics shapes the future political terrain. Overall, to gain 
analytical purchase, we need to know what salience means in practice, when policymakers 
judge between competing incentives. 
Scope: The size of an agency’s policy remit, its overall budget and its staff. 
The prevailing logic is that a larger agency, with a wider range of responsibilities, bigger staff 
and larger budget, is likely to be more robust to the whims of government (Lewis 2002; 
Carpenter and Lewis 2004; Berry et al. 2010). Yet, the empirical evidence is unclear (Boin et 
al. 2010). Further, interpretive research shows that scope is not as objectively fixed and 
measurable as might be expected. The remit and capacity of an agency shifts over time, and 
the trajectory of this movement feeds into broader perceptions of its legitimacy. For example, 
Corbett and Howard’s (2016) analysis of the fate of the Australian aid agency shows that the 
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larger and better funded the agency became, the bigger the target it presented, bringing it into 
conflict with other government departments and making it more vulnerable to partisan 
politics.  
Standing:  (a) the formal arrangements that structure the position and work of an agency and 
(b) the informal or perceived legitimacy of the agency among key policy actors. 
Large-n research on agencies seeks to disentangle the effects of different formal 
arrangements. The idea is to test whether certain sorts of agency configurations— conferring 
more independence or less; possessing decision-making functions or charged with 
implementation or mere scrutiny—enable greater success than others (Boin et al. 2010; 
O’Leary 2015; Bertelli and Sinclair 2016). Empirical patterns are unclear (Verhoest et al. 
2012). Further, interpretive work flips this presumption on its head: institutional 
configurations should not be seen as arbitrary variables that set in motion political dynamics. 
They are themselves products of political contestation (Howard 2016) and not fixed and 
determining. They can shift in response to perceived success or failure. For example, 
Boswell’s (2018) account of the contrasting trajectories of two arms-length bodies in the 
British health sector, shows how legal standing confers a formal authority that remains 
contingent on informal legitimacy.  
Overall, then, there is great value in adopting an interpretive orientation in unpacking the 
effects of salience, scope and standing on agency performance and survival. Such an 
approach is ideally suited to explaining the complex dynamics underpinning the fate of newly 
formed preventative health agencies. 
Method: Case selection, data collection and interpretive analysis 
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The empirical analysis draws on in-depth qualitative research across three cases – the 
Australian National Preventative Health Agency (ANPHA), New Zealand’s Health 
Promotion Agency (HPA) and Public Health England (PHE). In this section, we justify case 
selection, outline and reflect on the dataset, and explain the analytical process. 
One reason for drawing this comparison is the contemporaneous nature of the cases. Both 
policy and academic discussion on agencies with responsibility for preventative health tends 
to be dominated by ‘success stories’ – shining examples like VicHealth that have been 
established for decades. Yet, as our review of the agency literature shows, such success is 
preciously rare and historically contingent. Our three cases all emerged in the last decade at 
the height of the prevention agenda, and so their contrasting fates are likely to provide more 
relevant lessons for both research and practice.  Moreover, comparing case material across 
these three countries is a proven selection strategy in political science and public 
administration scholarship (Rhodes et al. 2009; Marsh and Miller 2013; Grube and Howard 
2017). Australia, New Zealand and England share a set of ‘family resemblances’ that enable 
fruitful comparison [omitted]. Not all background features are kept constant since, for 
example, New Zealand is relatively small, Australia has a federal system of government, and 
England has complex multi-level governance arrangements that intersect and overlap. 
Nevertheless, the three cases share an inherited set of cultural, political and administrative 
features and traditions, and they remain entangled in (mostly) informal relationships that 
enable sharing and mutual learning across policy sectors. Indeed, many of our interview 
participants had professional experience across these jurisdictions and almost all had strong 
familiarity and close personal ties. These recurring traits, traditions and ties can help to 
structure comparative analysis and provide lessons from the contrasting experiences of 
ANPHA, HPA and PHE. 
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Data collection for each case entailed extensive background desk research, focused on 
Parliamentary Hansard surrounding the establishment of each agency, policy documents 
outlining and refining its remit and responsibilities, and public-facing material archived on 
relevant web pages. The bulk of the analysis, however, draws on the material collected 
through 25 semi-structured interviews with former and current agency executives and board 
members, and with stakeholders in government (across relevant departments and agencies) 
and beyond (including professional, charity and industry representatives), conducted between 
September 2016 and October 2017.  
INSERT TABLE 1 ABOUT HERE 
We were able to access key individuals across the Australian (10 interviewees) and English 
(8 interviewees) cases with relative ease, but found the New Zealand case more challenging. 
No one with formal links to HPA (board member, executive or official) was willing to 
commit to an interview (though one person did agree to formal correspondence via email) 
and several experts and advocacy group representatives were not at liberty to speak with us 
because of ongoing legal action. These challenges are indicative of the polarisation of 
preventative health in this case and the lack of legitimacy that the HPA enjoys among 
stakeholders. 
We identified actors through purposive sampling instructed by the initial documentary 
analysis, with a small degree of ‘snowballing’ from initial research participants. We obtained 
ethical clearance from the University of Southampton before embarking on the fieldwork, a 
condition of which was that we promise to protect participant anonymity where possible. In 
practice, because of the small and intimate nature of the policy networks surrounding these 
agencies, it was not possible to guarantee anonymity for all actors. In such cases, we obtained 
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consent to quote participants ‘on the record’ and in some instances sent a transcript of audio-
recorded interviews to participants for vetting and revision.  
We coded the interview data via a process of abduction common to interpretive research 
(Yanow and Schwartz-Shea 2012). It entails moving between the findings emerging in the 
empirical data and key themes emerging through critical engagement with the literature. It is 
an iterative -  not hydraulic and stepwise – process which prioritises reflection and refinement 
of the analytical categories and significant deliberation and judgment.  
Author A contacted participants, conducted the interviews and manually coded the interview 
material. Authors B and C produced a ‘synthetic’ review of policy theory and the secondary 
literature on prevention policy and institutionalisation (see [omitted]) to help situate the initial 
enquiry and present the eventual findings.   
 
Case 1: The Australian National Preventative Health Agency 
The Australian National Preventative Health Agency was established in 2011 on the back of 
concerted public health advocacy. Its chief value, as expressed by Health Minister Nicola 
Roxon in the initial mission documents, was to offer national leadership in the “ramping up” 
of the prevention agenda: 
[There] has never been a more important time to tackle preventable diseases. That is 
why the Gillard Government established the Australian National Preventive Health 
Agency (ANPHA) as Australia’s first national preventive health agency with the 
capacity to lead, support and coordinate the “ramping up” of prevention and health 
promotion effort. (Roxon in ANPHA 2011) 
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The agency lasted less than 2 years before being de-funded in 2013. The incoming Coalition 
government had attempted to shut it down on the basis of ‘duplication of effort’ with its 
parent Department of Health, but could not achieve the requisite numbers in the House. 
ANPHA therefore reached a messy denouement, de-funded but not abolished amid a climate 
of distrust. This disquiet spilled over into a scandal in the local tabloid newspapers, regarding 
an acrimonious contractual dispute between the government and ANPHA’s chief executive. 
What generated this antipathy and controversy? 
Salience: Too hot 
ANPHA was an idea that had been floating around in Australia for a long time. It was pushed 
strongly by influential public health expert advocates who had been instrumental in the 
success of VicHealth and its world-leading role in tobacco control policy (Galbally 2004). 
This long-cherished plan for institutional leadership gained traction with the election of a 
Labor Government in 2007, after four terms of John Howard’s conservative Coalition. Labor 
had signalled greater emphasis on preventative health in the lead-up to the campaign and the 
new Minister of Health, Nicola Roxon, was especially receptive to prevention ideas. The 
specific plan for a dedicated agency first emerged formally on the national agenda as a Big 
Idea thrown up in the 2020 Summit (a showpiece innovation in expert engagement early in 
the new government’s term). It was fleshed out in the National Preventative Health Taskforce 
(expert panel convened by the government). 
This history highlights two related problems in relation to salience. First, it made ANPHA a 
partisan institution. Its origin thwarted the efforts of ANPHA’s leadership to build and sustain 
relationships with the Opposition. Second, these initial institutional processes left an 
unfortunate legacy: ANPHA’s remit echoed that of the Taskforce, clustered around the major 
causes of preventable non-communicable diseases (tobacco, alcohol, obesity). Exemplifying 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
15 
 
the staunch industry resistance in Baker et al.’s (2017) recent account of the politics 
surrounding obesity in Australia, ANPHA was constituted directly in opposition to Big 
Tobacco, Big Alcohol and Big Food.  It had powerful enemies from the outset, as one official 
mused: 
[We] got rung by the secretary and told to lay off the alcohol industry. [The alcohol 
industry] were in with the Minister. The Minister’s advisor was telling us they weren’t 
so bad, and to lay off them. This is a Labor Minister! 
Scope: Small capacity, unruly remit  
ANPHA’s remit was to produce a wide variety of outputs. As forgers of a brand new agency, 
the initial staff spent its early life working out what to do. An industry representative put it 
witheringly: 
I think it was set up as a gesture to the public health lobby, saying ‘Okay, you’ve 
asked for it, so here it is.’  And I suspect the public health lobby were surprised when 
they got this, and they hadn’t thought enough and given the government enough 
insight as to what they expected it would do.  I think it was the classic case of, you 
know, ‘Be careful for what you ask for because you might actually get it!’ 
From the perspective of public health advocates and the officials involved, the issue was a 
lack of resources and capacity. ANPHA was run on a shoestring, with a skeleton staff mostly 
relocated to a small office across town from the Health Department. This combination made 
ANPHA’s sustainability unlikely. It had a big and unruly remit and routine contact with other 
powerful bodies. In particular, the Department of Health’s leadership was widely seen as 
patch protective. Most of the interview participants noted intense hostility to ANPHA 
(although few were willing to go on the record): 
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Jane Halton, the Secretary of the Department, was really opposed to the idea and it 
was only really that the Minister said, ‘No, it’s going to happen,’ that ANPHA was 
created. But it was always a bit constrained in terms of its budget, its operational 
capacity, its independence. 
The task of appealing to and appeasing these stakeholders was, in the word of one 
experienced campaigner, ‘like dancing with an octopus’.  
Standing: No ‘quick wins’ 
Many of our participants attributed ANPHA’s failure to a lack of strong institutional standing. 
Although branded as an agency, in practice ANPHA lacked many features associated with a 
fully autonomous status. It remained under the thumb of the Department, lacking its own 
protected budget, direct line to the Minister or Treasury, or independent and empowered 
board. One advisory group member surmised: 
What we wanted to happen was clear: we wanted a separate agency that would be 
responsible for prevention policy. And the structure was wrong from the outset. 
This institutional architecture reflected and reinforced the wariness that key actors in and 
outside government had about the new agency (see also Baker et al. 2017). A senior civil 
servant explained:  
[Public health] people really wanted – you know, if it was going to be able to do the 
things that the Commonwealth Department couldn’t do – they wanted it to be really 
independent.  But that was a very hard ask, especially when, increasingly, Treasuries 
don’t want a plethora of new agencies and bodies. 
In any case, the failure to get ‘quick wins’ sealed its fate. The unclear remit and piecemeal 
programme of work made it difficult to build a reputation for credible performance. It had 
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only a small, short-term tranche of funding for research grants, and otherwise largely 
absorbed existing social marketing programmes from the line department. In fact, there was a 
strong feeling that absorbing this work might have done ANPHA more reputational harm 
than good: 
I think they felt a bit constrained as far as what they could do, so they kind of had to 
prove themselves by not being too controversial. … Really I was pretty frustrated 
with that … it was spectacularly unsuccessful.   
The leadership of ANPHA, hamstrung by capacity constraints, could not produce the sort of 
outcomes that would make it an indispensable part of the machinery of government. It thus 
became an obvious target of the incoming Coalition government’s plans for ‘quangocide’, 
and has lain dormant since. 
Case 2: New Zealand’s Health Promotion Agency 
The Health Promotion Agency was established in 2012. It was envisaged as an institution that 
would build on recent successes in reforming and enhancing primary healthcare and 
community health in New Zealand: 
The bill’s intention with the Health Promotion Agency is first and foremost to create 
an agency that will deliver better public health outcomes for New Zealanders… A 
more integrated and efficient approach to health promotion across the range of public 
health issues will, in turn, deliver better public health outcomes. (Goodhew, 2012) 
The HPA’s establishment was impacted by the legacy of an earlier effort at substantive 
institutionalisation in preventative health, the quickly aborted Public Health Commission in 
the mid-1990s. Mirroring ANPHA’s more recent experience in Australia, the Commission 
had been quickly disestablished due largely to an antagonistic relationship with the Ministry 
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of Health and powerful vested interests in industry (see Hornblow 1997). As such, HPA was 
to take a very different tack. Its officials set about quietly notching up ‘quick wins’ on 
uncontroversial issues and cultivating a subterranean public profile that would not draw the 
agency into controversy. However, the HPA was suddenly thrust into the national spotlight 
when it was implicated in investigative journalist Nikki Hager’s (2014) explosive Dirty 
Politics. Hager’s book, which took over the national news cycle when launched during the 
2014 General Election campaign, impugned the reputation of the National government and 
revealed the role of government officials and aides in a ‘black ops’ communications strategy. 
It had emerged in the course of Hager’s investigation that Katherine Rich, former National 
MP, HPA board member and then head of NZ’s peak food lobby group, had links to a PR 
firm which consistently planted and promoted stories attacking the credibility of public health 
advocates. These revelations sparked outrage in the public health community. The scandal set 
in train an acrimonious debate, including a public letter signed by 33 scientists asking the 
government to respond to a perceived conflict of interest on the HPA board. The outcry was 
followed swiftly by litigation on both sides. The response of the HPA has been to go to 
ground again, such that there was sufficient anxiety, over two years later, that no one would 
speak with us directly.  
HPA has thus enjoyed greater ‘success’ than its ANPHA counterpart in terms of longevity, 
but has thus far been equally limited in terms of its capacity to institutionalize preventative 
health. How might we explain this? 
Salience: Too cold 
HPA’s relationship to political salience is in many respects the opposite extreme to the 
experience of ANPHA. First, HPA began life with a tightly circumscribed remit on health 
promotion, especially via social marketing. Social marketing, in the absence of broader 
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structural changes, is often characterised often as something that governments like to do to be 
seen to tackle chronic disease without making any of the hard or contentious decisions 
involved (Rayner et al. 2006). 
Second, HPA entailed a rather uneasy and incoherent compromise between the progressive 
forces of preventative health and the conservative National-led government and its allies in 
industry. The clearest symbol was the installation of Rich on the board, given her National 
Party background and role as food lobbyist. Preventative health advocates were caught in an 
awkward but familiar bind - whether to work with the new institution for change from within 
or to critique it from the outside: 
This is a small country. We don’t have that many experts in anything that you can 
ensure that everybody’s a pure independent on everything, unless they’re so 
independent they’ve got no idea what they’re doing…. Quite simply, if I join the ones 
trying to get rid of Katherine Rich: (a) I know it wouldn’t work and (b) I’d probably 
lose [existing influence]. I’m not prepared to sacrifice all the other useful things we 
do for the sake of trying to pin one person. 
Scope: Reasonable capacity, narrow remit 
HPA seeks to be apolitical, to project the arms-length independence that has long been 
central to the appeal of agencies. Even when under attack from public health advocates and 
Opposition MPs in the wake of the Dirty Politics scandal, HPA leadership has tried to ride 
out the controversy. They have sought refuge in the agency’s technical policy mission, and 
downplayed or entirely ignored political implications, as journalist Peter Newport (2015) 
captured in a feature on the scandal for Metro magazine: 
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It took almost a week to get one sentence from their chair, Dr Lee Mathias… “What 
about the detailed points in the scientists’ letter about a conflict of interest?” I 
persisted. [A communications manager] pointed out we had received the HPA’s 
official “single sentence statement” and hung up. 
Its capacity is tightly channelled and constrained. Health promotion is interpreted as a 
technical exercise in administration and implementation. 
Standing: Subordinate 
HPA continues to enjoy legal standing as an arms-length agency, and a valuable source of 
expertise within government on social marketing. However, its informal standing among key 
stakeholders and in the public sphere is poor. At the time, prominent public health expert 
Professor Boyd Swinburn expressed outrage in his media commentary: 
[Katherine Rich is] sitting on the board of the Health Promotion Agency, while at the 
same time she's denigrating public health professionals, and undermining public 
health policy (Radio NZ, 2014, Sept6). 
HPA is a stark example of how institutional ‘success’ as measured in longevity, capacity and 
formal standing does not equal ‘success’ in terms of policy advocacy or outcomes. Although 
there are suggestions NZ’s new Labour-led government may induce changes in the 
institutional landscape around prevention, HPA has historically been more of an obstacle than 
a vehicle for leadership on preventative health policy. 
 
Case 3: Public Health England 
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Public Health England (PHE) came about through the major health service reforms under 
David Cameron’s Coalition government. It brought together under one umbrella some pre-
existing arms-length bodies and new dedicated functions: 
By creating this new integrated public health organisation, we believe Public Health 
England can develop to be a global leader in translating evidence into practice, and in 
tackling hitherto intractable problems.  (Healthy Lives: Healthy People, p16). 
Though subject to teething problems and controversy in its short history, PHE has enjoyed a 
happier combination of institutional ‘success’ and policymaking gains on preventative health. 
How has it managed this? 
Salience: Just right 
Two factors explain its salience. First, it was set up by the Coalition government but retains a 
bipartisan public image. The legislation establishing PHE received strong support from all 
main parties. Indeed, the main delays to this aspect of the Bill concerned a call for 
amendments to strengthen the independent standing of the new agency, supported and 
advocated by Peers on all sides (see House of Lords 2012). This was a deliberate, 
orchestrated campaign to shore up the informal legitimacy of the new body. 
Of course, a bipartisan image does not just emerge in a vacuum. It has to be fought for, 
courted and reinforced. Importantly, the logic underpinning the establishment of PHE lay in 
administrative efficiency rather than a more overtly political drive for preventative policy 
outcomes. Though the Coalition government’s health reforms under Andrew Lansley were 
extremely controversial and divisive on the whole, the particular move to shift public health 
away from Westminster responsibility and towards the jurisdiction of local government was 
widely seen as long overdue common sense. One public health advocate explained: 
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Establishing PHE was a sort of necessity once the decision had been taken by the then 
Secretary of State to move public health into local government. It required, you know, 
an aggregation of the public health resources that were in regional offices.… I see the 
move of public health from the NHS to local government as an historic and necessary 
move.  
The second key factor has been the organization’s wily engagement with salient issues. One 
key facilitator is their willingness to engage. The distinction here with the HPA in NZ is 
instructive: PHE does not ‘go to ground’ or refuse to countenance political topics. It tackles 
them, and is forthright in its public defence of stated positions. Its approach to engagement is 
sufficiently low key: PHE has been careful to follow established protocols of independent 
advice and, in doing so, not to always side with the progressive public health lobby. The 
organisation engages, but only on the basis of being a ‘knowledge broker’, which allows it to 
perform and reinforce its independence. The most famous example has been around e-
cigarettes. A PHE review in 2015 claimed that e-cigarettes were 95% safer than traditional 
tobacco, making headlines around the world (PHE, 2015). The stance of most public health 
advocates is that the harms of e-cigarettes are not well understood, and the motives and 
practices of the corporations producing them ought to give reason for suspicion. The 95% 
safer verdict, then, was received with considerable hostility. One expert advocate reflected in 
our interview: 
It has been the most difficult area certainly.  Arguably Public Health England is out of 
step with not just the rest of the world but even within the British Isles. We are 
working on the principle that we’ll disagree in private and hope to come to positive, 
common views in the public.  
Scope: Big capacity, flexible remit 
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Of the three bodies in our analysis, PHE enjoys by far the greatest capacity. Size is often 
assumed to correlate with agency success but the relationship is not straightforward. For 
example, the merger of smaller bodies – including the Health Protection Agency and the 
National Treatment Agency for Substance Misuse – into PHE entailed some degree of 
conflict, as the actors within constituent parts were bedded into a new structure that reduced 
some of their autonomy and cut into budgets. One official, directly affected by the process, 
put it in personal terms: 
The main issue on the transfer into Public Health England was, for example, for me 
personally, I’d been at the top table … I came into Public Health England lower down 
the hierarchy, and the resources that I’d been able to draw on directly were dispersed 
into other parts of PHE. 
But the trade-off from these internal organizational challenges has been greater flexibility in 
terms of PHE’s remit on prevention. It enjoys greater capacity and a larger budget than its 
counterparts in NZ and Australia, so has more discretionary resources to dedicate to 
preventative issues.  
Standing: Prevention ‘ninjas’ 
PHE enjoys strong legal independence, albeit primarily in an advisory function. The story 
behind its formal status is complex and contingent. There was particular sensitivity around 
absorbing the functions of the Health Protection Agency – an organisation staffed by 
clinicians and scientists rather than bureaucrats – many of whom would balk at any 
semblance of political interference. One of the architects of the transition to PHE explained 
the balancing act in its founding Framework Agreement:   
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So we talk about ‘operational autonomy’ for PHE. The way that I was trying to 
articulate it was you can talk about public health evidence, but Public Health England 
should just accept that Ministers take decisions at the end of the day and they will take 
a variety of issues into account. 
Formal independence obviously does not translate into policy action. More surprisingly, it 
does not necessarily translate into bold leadership on the prevention agenda either. PHE was 
from the outset in an excellent position to get ‘quick wins’ within government. It has done so 
chiefly by foregrounding the more technical, uncontroversial aspects of its work that it was 
able to carry on with. In particular, a handful of established features and functions that 
became amalgamated within PHE – for example, drug treatment programmes – ensure 
support, respect and profile for the organisation as a whole. These ‘core responsibilities’ give 
others in PHE the freedom to work on thornier prevention issues around obesity or alcohol 
and tobacco consumption, but subject to a scientific identity which appears to constrain the 
willingness of researchers to be seen to act too politically. Put simply by one of our 
departmental interviewees, PHE officials often bind their own hands in the promotion of 
prevention policies; they are desperate to avoid any appearance of going beyond the evidence 
in support of the key policy goals of public health advocates. 
Even in more expressly contentious work, PHE has been careful to walk a fine line: 
upholding independence from government, but being careful not to lapse into preventative 
health ‘lobbying’. This tendency towards muted advocacy has drawn the ire of some in public 
health. One official explained: 
I think it’s difficult for stakeholders sometimes to understand how policy is made.  I 
can remember one person saying to me, about five years ago, [taps on table] ‘You just 
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need to tell the minister they need to spend more money on alcohol treatment.  If you 
give them the right facts, they’ll do it.’   
The upshot is that, in the imagery of one interviewee, PHE officials feel they are operating as 
‘prevention ninjas’. Rather than providing outright leadership for preventative health, they 
pursue this agenda by stealth, building and leveraging good will with other powerful actors. 
The official explained: 
So, for example, what would be the point of doing something which upset the NHS, if 
you want them to deliver some evidence-based interventions which are likely to have 
an impact on public health? So we’ve got to play canny. It’s about using our 
relationships. 
 
Conclusion: Lessons for the goal of institutionalising prevention 
Our findings, summarized in table 2, present a nuanced picture. PHE has enjoyed more 
success than HPA and ANPHA. However, it is hardly a beacon for preventative health 
leadership. These findings reinforce Schang et al.’s (2011) conclusion that an agency is no 
magic bullet for prevention. Its introduction may send a positive message, but does not 
represent major policy change in itself. In whatever form, the prevention agenda in health 
bumps up against conflicting ideological values and powerful corporate interests. The quick 
death of ANPHA and the bubbling controversy over the HPA in NZ highlight what is at stake. 
Our participants across the three cases were quick to emphasise that achieving policy change 
in this context is immensely difficult, and that no institutional fix can shortcut or depoliticise 
the process. Institutionalization simply redefines the terrain on which familiar political battles 
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are fought.   The experiences of the agencies allow us to draw three provisional lessons about 
these political battles. 
INSERT TABLE 2 ABOUT HERE 
The first lesson is that the path to substantive institutionalisation is winding and treacherous. 
The success of agencies dedicated to prevention, understood even in the limited terms of 
mere survival and reputation, depends on a configuration of factors that is ‘just right’ for the 
specific context. PHE and its officials continue to walk a fine line. They have to engage with 
controversies that emerge while retaining bipartisan buy-in overall. They cover a large policy 
remit but devote key resources to prevention causes specifically. They shore up their 
reputation as independent ‘knowledge brokers’ without straying into overt advocacy.  The 
experiences of ANPHA and the HPA show that failure to maintain the balance in relation to 
just one of these factors can have problematic consequences for the others. It is a delicate 
balance to maintain, especially as the prevention agenda and the political context surrounding 
it evolve over time. 
The second lesson is that leadership in preventative health – at least in agencies – may not be 
best served by bold public advocacy and a strong policy agenda. Bold public advocacy and a 
heavy emphasis on upstream prevention policy in the Australian case meant powerful 
enemies and a short lifespan. More subtle persuasion, and a deliberate emphasis on technical 
‘core responsibilities’ over thornier prevention measures in the English case, has contributed 
to widespread legitimacy. This comparison suggests it may be more profitable to foreground 
the widely-accepted goods of public health and background the controversial aspects of 
prevention.     
The final lesson is that institutional ‘success’ does not necessarily go hand-in-hand with 
policy gains for the prevention agenda. Our cases reveal that the work of building and 
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maintaining political support is not always compatible with the work of advancing 
preventative health policy. The management of these tensions can frustrate the most vocal 
proponents of progressive policy action.  Indeed, many of our participants—particularly those 
in Australia burned by ANPHA’s failure—were keen to reflect on the limits to the agency 
model altogether. One concluded our interview by reflecting: 
I think in many ways having an agency almost does the work a disservice. It’s 
important for profile. It’s important for branding and visibility, etc. But… in a large 
bureaucracy where governments come and go, it makes you vulnerable. When the 
pendulum swings and it’s time for smaller government, standalone agencies are 
always going to be the first hit. 
Our analysis shows that institutionalising prevention via dedicated agencies seems destined 
to disappoint, but that some solutions are far less disappointing than others. So far, PHE 
represents the most feasible success story as the least-worst option available to public health 
advocates and policymakers.  
In that context, it is not surprising that many of our interviewees suggested alternative 
vehicles for leadership on the prevention agenda, within the heart of government departments 
or outside government entirely, in civil society. Although such suggestions represent an 
exciting angle for further research and experimentation, we urge caution because it is difficult 
to connect slow progress specifically to the role of agencies. Rather, many of these obstacles 
relate to wider issues of prevention – including its ambiguity, which contributes to false and 
ultimately unsustainable consensus – that would be present regardless of its institutional 
vehicle.   
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SSM Tables  
 
Table 1: Breakdown of interview participants 
 Australia New Zealand England Total 
Agency official 3 1 (via email 
correspondence) 
2 6 
Other civil 
servant 
1 1 3 5 
Expert advocate 6 5 3 14 
Total 10 7 8 25 
 
 
Table 2: Summary of key findings 
 ANPHA (Australia) HPA (NZ) PHE (England) 
Salience  
 
Too hot  
Setting agency up around 
against key industries 
ensured it had powerful 
enemies; also closely linked 
to Labor’s agenda so 
vulnerable to change of 
government 
Too cold  
Agency directed to 
promotion/social marketing 
and away from preventative 
regulation, with very close 
links to food and beverage 
industry. 
Just right 
Agency engages in 
controversial political issues 
but is careful not to ‘pick 
sides’; set up under 
Coalition and enjoys (and 
courts) a bipartisan image. 
 
Scope 
 
Small capacity, unruly 
remit 
A skeleton staff and short-
Reasonable capacity, 
restricted remit 
A mid-sized staff and stable 
Big capacity, flexible remit 
Large staff and budget 
merging respected agencies 
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term budget left to choose 
their own adventure, and 
inevitably cross paths with 
powerful rivals  
budget, but a very narrow 
remit focused on technical 
support and implementation 
– some internal squabbles 
but enables flexibility to 
pursue aspects of prevention 
agenda 
Standing 
 
No ‘quick wins’ 
Failed to notch up 
achievements or build 
relationships in short time-
span 
 
 
Subordinate 
Relationship with industry 
means they are under siege 
from public health experts, 
NGOs and advocates 
Prevention ‘ninjas’ 
Independent reputation 
ensures legitimacy but 
means the prevention 
agenda is pursued by stealth 
rather than through strong 
leadership   
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SSM Highlights 
 
This paper finds that: 
• Executive agencies are no magic bullet for the prevention agenda in 
health. 
• The viability of agencies depends on a complex, evolving mix of factors.  
• Sustaining political support for an agency can undermine policy progress. 
• Agency officials often act as prevention ‘ninjas’ rather than bold public 
leaders. 
 
